SacraRose Viridian Night Serum

SacraRose Viridian Night Serum
 
While you sleep, your skin works hardest to repair the day’s exposure. Yet many notice that redness, irritation, and dryness often feel more pronounced in the morning — as if the skin is struggling to restore balance overnight.
 
Viridian Night was created in recognition of this quiet nightly ritual. It pairs Blue Tansy’s rare azulene-rich calm with the softness of Rose and the steadying depth of Frankincense — botanicals long valued for their affinity with the skin.
 
When the skin remains agitated, the overnight repair process can feel incomplete. Dryness lingers, redness persists, and the complexion appears less settled upon waking.
 
Over time, this ongoing state of reactivity can interrupt the skin’s natural rhythm of renewal, making it harder to maintain the comfort and coherence you desire.
Viridian Night offers a gentle invitation for the skin to settle. Blue Tansy helps create a sense of cooling clarity. Rose brings softness and memory. Frankincense supports the skin’s natural architecture as it rebuilds. Together they form a serum that does not demand transformation but instead creates the conditions in which the skin can do what it already knows how to do — restore itself.
 
Night after night, many notice the skin feels less reactive and more at ease upon waking. The boundary between evening and morning becomes softer, more continuous.
 
Blue Tansy brings peace.
Rose brings remembrance.
Frankincense brings structure.
Skin brings its own quiet intelligence.
Viridian Night Serum is what happens when they meet in the dark.
 
Research on Key Botanicals
- Srivastava, J.K., et al. (2010). Chamomile: A herbal medicine of the past with bright future. *Molecular Medicine Reports*, 3(6), 895–901.
- Safayhi, H., et al. (1994). Chamazulene: A novel type of anti-inflammatory compound. *Planta Medica*, 60(5), 410–413.
- Bickers, D.R. & Athar, M. (2006). Oxidative stress in the pathogenesis of skin disease. *Journal of Investigative Dermatology*, 126(12), 2565–2575.